Výsledky vyhľadávania - "Adjuvant/methods"
-
1
Autori: a ďalší
Zdroj: New England Journal of Medicine. 393:37-50
Predmety: Adult, Male, Antibodies, Monoclonal, Humanized / adverse effects, Antibodies, Monoclonal, Humanized / administration & dosage, Young Adult, Chemotherapy, Adjuvant / methods, B7-H1 Antigen / analysis, B7-H1 Antigen / antagonists & inhibitors, Humans, Neoadjuvant Therapy / adverse effects, Antineoplastic Agents, Immunological / administration & dosage, Antineoplastic Agents, Immunological / adverse effects, Aged, Aged, 80 and over, Head and Neck Neoplasms / mortality, Head and Neck Neoplasms / pathology, Squamous Cell Carcinoma of Head and Neck / pathology, Middle Aged, Head and Neck Neoplasms / drug therapy, Neoadjuvant Therapy / methods, Progression-Free Survival, Squamous Cell Carcinoma of Head and Neck / surgery, Intention to Treat Analysis, B7-H1 Antigen / metabolism, Treatment Outcome, Head and Neck Neoplasms / surgery, Squamous Cell Carcinoma of Head and Neck / drug therapy, Female, Chemotherapy, Adjuvant / adverse effects, Squamous Cell Carcinoma of Head and Neck / mortality
Popis súboru: application/pdf
-
2
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: The Lancet Respiratory Medicine. 13:221-233
Predmety: Male, corticosteroid, community-acquired pneumonia, Community-Acquired Infections/drug therapy, adjuvant therapy, Pneumonia, Adrenal Cortex Hormones/therapeutic use, Middle Aged, Severity of Illness Index, Pneumonia/drug therapy, corticosteroids, [SDV] Life Sciences [q-bio], Community-Acquired Infections, Treatment Outcome, Adrenal Cortex Hormones, Chemotherapy, Adjuvant, Chemotherapy, Humans, Adjuvant/methods, Female, Randomized Controlled Trials as Topic, Aged
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39892408
https://hdl.handle.net/11368/3113759
https://www.sciencedirect.com/science/article/pii/S2213260024004053?via=ihub
https://pure.eur.nl/en/publications/cbc3cff6-2d45-40b9-8648-12ed88b2bacf
https://doi.org/10.1016/S2213-2600(24)00405-3
https://inserm.hal.science/inserm-04976394v1
https://doi.org/10.1016/s2213-2600(24)00405-3
https://hdl.handle.net/11368/3113759
https://doi.org/10.1016/S2213-2600(24)00405-3
https://www.sciencedirect.com/science/article/pii/S2213260024004053?via=ihub -
3
Autori: a ďalší
Zdroj: Henriksen, T V, Demuth, C, Frydendahl, A, Nors, J, Nesic, M, Rasmussen, M H, Larsen, O H, Jaensch, C, Løve, U S, Andersen, P V, Kolbro, T, Thorlacius-Ussing, O, Monti, A, Kildsig, J, Bondeven, P, Schlesinger, N H, Iversen, L H, Gotschalck, K A & Andersen, C L 2025, 'Timing of ctDNA Analysis Aimed at Guiding Adjuvant Treatment in Colorectal Cancer', Clinical Cancer Research, vol. 31, no. 9, pp. 1676-1685. https://doi.org/10.1158/1078-0432.CCR-24-3200
Predmety: Male, Adult, Aged, 80 and over, Time Factors, Liquid Biopsy, Liquid Biopsy/methods, Middle Aged, Prognosis, Colorectal Neoplasms/genetics, Circulating Tumor DNA, Circulating Tumor DNA/blood, Chemotherapy, Adjuvant, Biomarkers, Tumor, Humans, Female, Biomarkers, Tumor/genetics, Colorectal Neoplasms, Chemotherapy, Adjuvant/methods, Aged, Neoplasm Staging
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39976513
-
4
Autori: a ďalší
Zdroj: Sci Rep
Sa-Nguansai, S, Rattanasiri, S, Pornsuriyasak, P, Numthavaj, P, McKay, G J, Attia, J & Thakkinstian, A 2025, 'A network meta-analysis of efficacy and safety of adjuvant targeted therapy or immunotherapy in non-small cell lung cancer', Scientific Reports, vol. 15, 21696. https://doi.org/10.1038/s41598-025-05823-2Predmety: Treatment Outcome, Protein Kinase Inhibitors/therapeutic use, Carcinoma, Non-Small-Cell Lung/drug therapy, ErbB Receptors/antagonists & inhibitors, Immunotherapy/methods, Humans, Network Meta-Analysis as Topic, name=SDG 3 - Good Health and Well-being, Lung Neoplasms/drug therapy, Molecular Targeted Therapy/methods, Article, Chemotherapy, Adjuvant/methods, Randomized Controlled Trials as Topic
Popis súboru: application/pdf
Prístupová URL adresa: https://pure.qub.ac.uk/en/publications/470fbca2-94a7-49b8-b0ba-5e3fafed2560
-
5
Autori: a ďalší
Zdroj: Breast Cancer Res Treat
Predmety: Adult, Aged, 80 and over, 0301 basic medicine, Gene Expression Profiling, Clinical Decision-Making, Breast Neoplasms, Middle Aged, Prognosis, Clinical Trial, Risk Assessment, Clinical Decision-Making [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Breast cancer, Neoplasm Recurrence, Local/pathology [MeSH], Breast Neoplasms/therapy [MeSH], Neoplasm Staging [MeSH], 21-gene assay, Adjuvant treatment, Neoplasm Recurrence, Local/genetics [MeSH], Ki-67 Antigen/metabolism [MeSH], Chemotherapy, Adjuvant/methods [MeSH], Biomarkers, Tumor [MeSH], Risk Assessment/methods [MeSH], Registry, Breast Neoplasms/pathology [MeSH], Female [MeSH], Recurrence Score, Adult [MeSH], Humans [MeSH], Prospective Studies [MeSH], Breast Neoplasms/genetics [MeSH], Breast Neoplasms/drug therapy [MeSH], Breast Neoplasms/metabolism [MeSH], Middle Aged [MeSH], Prognosis [MeSH], Gene Expression Profiling/methods [MeSH], Ki-67, Registries [MeSH], 03 medical and health sciences, Ki-67 Antigen, 0302 clinical medicine, Chemotherapy, Adjuvant, Biomarkers, Tumor, Humans, Female, Prospective Studies, Registries, Neoplasm Recurrence, Local, Aged, Neoplasm Staging
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38874685
https://repository.publisso.de/resource/frl:6518260 -
6
Autori: a ďalší
Zdroj: Breast Cancer Res Treat
Predmety: 0301 basic medicine, ddc:610, Epidemiology, 610 Medizin, Triple Negative Breast Neoplasms, Breast Neoplasms, Combined Modality Therapy, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Chemotherapy, Adjuvant, Triple negative breast cancer · Timing of adjuvant chemotherapy · Population-based cancer registry · Outcomes in TNBC · Routine practice data, Humans, Female, Female [MeSH], Timing of adjuvant chemotherapy, Triple Negative Breast Neoplasms/pathology [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Neoplasm Staging [MeSH], Triple negative breast cancer, Population-based cancer registry, Chemotherapy, Adjuvant/methods [MeSH], Outcomes in TNBC, Routine practice data, Combined Modality Therapy [MeSH], Breast Neoplasms/pathology [MeSH], Retrospective Studies, Neoplasm Staging
Popis súboru: application/pdf
-
7
Autori: a ďalší
Zdroj: Oncologist
The oncologist, vol. 30, no. 3Predmety: 03 medical and health sciences, 0302 clinical medicine, Humans, Oximes/administration & dosage, Oximes/therapeutic use, Oximes/pharmacology, Melanoma/drug therapy, Melanoma/genetics, Melanoma/pathology, Melanoma/mortality, Male, Female, Middle Aged, Imidazoles/therapeutic use, Imidazoles/administration & dosage, Imidazoles/pharmacology, Proto-Oncogene Proteins B-raf/genetics, Pyrimidinones/administration & dosage, Pyrimidinones/therapeutic use, Pyrimidinones/pharmacology, Pyridones/administration & dosage, Pyridones/therapeutic use, Pyridones/pharmacology, Retrospective Studies, Adult, Aged, Neoplasm Staging, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/pharmacology, Chemotherapy, Adjuvant/methods, Neoplasm Recurrence, Local/drug therapy, Neoplasm Recurrence, Local/pathology, Skin Neoplasms/drug therapy, Skin Neoplasms/pathology, Skin Neoplasms/genetics, Skin Neoplasms/mortality, Mutation, Disease-Free Survival, BRAF mutation, dabrafenib, melanoma, relapse-free survival, trametinib, Melanoma and Cutaneous Malignancies
Popis súboru: application/pdf
-
8
Autori: a ďalší
Zdroj: Radiat Oncol
Radiation Oncology, Vol 19, Iss 1, Pp 1-9 (2024)Predmety: Adult, Intraoperative radiotherapy, Genital Neoplasms, Female, Radical surgery, R895-920, Electron, Tertiary Care Centers, Cohort Studies, Medical physics. Medical radiology. Nuclear medicine, Recurrence, Aged, 80 and over [MeSH], Radiotherapy, Adjuvant/methods [MeSH], Aged [MeSH], Tertiary Care Centers [MeSH], Radiation therapy, Neoplasm Recurrence, Local/pathology [MeSH], Cohort Studies [MeSH], Genital Neoplasms, Female/radiotherapy [MeSH], Combined Modality Therapy [MeSH], Female [MeSH], Adult [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Gynecological cancer, Genital Neoplasms, Female/pathology [MeSH], Genital Neoplasms, Female/surgery [MeSH], Survival Rate [MeSH], Neoplasm Recurrence, Local/radiotherapy [MeSH], Research, Prognosis [MeSH], High-dose-radiotherapy, Intraoperative Care [MeSH], Genital Neoplasms, Female/mortality [MeSH], Humans, RC254-282, Aged, Retrospective Studies, Aged, 80 and over, Intraoperative Care, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Prognosis, Combined Modality Therapy, Survival Rate, Female, Radiotherapy, Adjuvant, Neoplasm Recurrence, Local
Popis súboru: pdf
-
9
Autori: a ďalší
Zdroj: BMC Cancer
BMC Cancer, Vol 24, Iss 1, Pp 1-16 (2024)Predmety: Male, Adult, Proximal femoral metastasis, Bone Neoplasms, Breast Neoplasms, Osteolysis, Kaplan-Meier Estimate, Humans, Femur, RC254-282, Aged, Retrospective Studies, Aged, 80 and over, Osteolytic bone lesions, Aged, 80 and over [MeSH], Femoral Neoplasms/radiotherapy [MeSH], Radiotherapy, Adjuvant/methods [MeSH], Aged [MeSH], Prostatic Neoplasms/mortality [MeSH], Radiotherapy, Adjuvant/adverse effects [MeSH], Prostatic Neoplasms/pathology [MeSH], Femoral Neoplasms/secondary [MeSH], Breast Neoplasms/radiotherapy [MeSH], Prostatic Neoplasms/radiotherapy [MeSH], Osteolysis/etiology [MeSH], Multimodal cancer therapies, Fractures, Spontaneous/surgery [MeSH], Palliative Care/methods [MeSH], Bone Neoplasms/surgery [MeSH], Male [MeSH], Breast Neoplasms/surgery [MeSH], Prostatic Neoplasms/surgery [MeSH], Breast Neoplasms/mortality [MeSH], Breast Neoplasms/pathology [MeSH], Bone Neoplasms/radiotherapy [MeSH], Female [MeSH], Adult [MeSH], Intramedullary nailing, Kaplan-Meier Estimate [MeSH], Humans [MeSH], Fractures, Spontaneous/etiology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Impending fracture, Skeletal-related events, Femur/surgery [MeSH], Femur/pathology [MeSH], Bone Neoplasms/secondary [MeSH], Femoral Neoplasms/mortality [MeSH], Bone Neoplasms/mortality [MeSH], Pathological fracture, Femur/radiation effects [MeSH], Research, Femoral Neoplasms/surgery [MeSH], Femoral Neoplasms, Palliative Care, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prostatic Neoplasms, Middle Aged, Fractures, Spontaneous, Female, Radiotherapy, Adjuvant
-
10
Autori: a ďalší
Zdroj: Clinical Cancer Research. 29:4908-4919
Predmety: Triple Negative Breast Neoplasms, Sciences bio-médicales et agricoles, Prognosis, Triple Negative Breast Neoplasms -- drug therapy -- genetics -- pathology, Disease-Free Survival, 3. Good health, Adjuvant -- methods, Treatment Outcome, Chemotherapy, Adjuvant, Chemotherapy, Humans, Cyclophosphamide
Popis súboru: 1 full-text file(s): application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37733800
-
11
Autori: a ďalší
Zdroj: BMC Cancer
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)Predmety: Adult, Rural Population, Survival, Receptor, ErbB-2, Breast Neoplasms, Ethiopia, Aged [MeSH], Intrinsic subtypes, Receptor, ErbB-2/metabolism [MeSH], Ethiopia/epidemiology [MeSH], Breast Neoplasms/therapy [MeSH], PAM50, Africa, Chemotherapy, Adjuvant/methods [MeSH], Breast Neoplasms/mortality [MeSH], Breast Neoplasms/pathology [MeSH], Female [MeSH], Receptors, Estrogen/metabolism [MeSH], Adult [MeSH], Receptors, Progesterone/metabolism [MeSH], Humans [MeSH], Prospective Studies [MeSH], Breast Neoplasms/genetics [MeSH], Breast Neoplasms/drug therapy [MeSH], Breast Neoplasms/metabolism [MeSH], Middle Aged [MeSH], Breast Cancer, Rural Population [MeSH], Immunohistochemistry [MeSH], Biomarkers, Tumor/metabolism [MeSH], Research, Prognosis [MeSH], Gene Expression Profiling [MeSH], Biomarkers, Tumor, Humans, Prospective Studies, RC254-282, Aged, ddc:610, Gene Expression Profiling, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Prognosis, Immunohistochemistry, Receptors, Estrogen, Chemotherapy, Adjuvant, Female, Receptors, Progesterone
Popis súboru: application/pdf
-
12
Autori: a ďalší
Zdroj: Cancer Immunol Immunother
Predmety: Male, Aged, 80 and over, Skin Neoplasms, Research, Aged, 80 and over [MeSH], Melanoma, ≥ 75 years, Aged [MeSH], Skin Neoplasms/drug therapy [MeSH], Nivolumab/adverse effects [MeSH], Male [MeSH], Immune Checkpoint Inhibitors/adverse effects [MeSH], Chemotherapy, Adjuvant/methods [MeSH], Elderly patients, Melanoma/drug therapy [MeSH], Female [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Melanoma/mortality [MeSH], Immune Checkpoint Inhibitors/therapeutic use [MeSH], Adjuvant therapy, Melanoma/immunology [MeSH], Antibodies, Monoclonal, Humanized/therapeutic use [MeSH], Immune checkpoint inhibitor, Skin Neoplasms/mortality [MeSH], Nivolumab/therapeutic use [MeSH], Antibodies, Monoclonal, Humanized/adverse effects [MeSH], Middle Aged, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Nivolumab, 0302 clinical medicine, Chemotherapy, Adjuvant, Humans, Female, Immune Checkpoint Inhibitors, Aged, Retrospective Studies
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38969911
https://repository.publisso.de/resource/frl:6524688 -
13
Autori: a ďalší
Zdroj: Breast Cancer Res
Breast Cancer Research, Vol 26, Iss 1, Pp 1-11 (2024)Predmety: Adult, Neoplasm, Residual, Receptor, ErbB-2, Biopsy, Breast Neoplasms, Disease-Free Survival, Breast cancer, Lymphocytes, Tumor-Infiltrating, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Humans, TILs, RC254-282, Aged, Research, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Serial biopsies, Middle Aged, Prognosis, Neoadjuvant Therapy, Ki-67 Antigen, Treatment Outcome, Receptors, Estrogen, Chemotherapy, Adjuvant, Neoadjuvant therapy, Aged [MeSH], Receptor, ErbB-2/metabolism [MeSH], Neoadjuvant Therapy/methods [MeSH], Ki-67 Antigen/metabolism [MeSH], Chemotherapy, Adjuvant/methods [MeSH], Breast Neoplasms/mortality [MeSH], Breast Neoplasms/pathology [MeSH], Female [MeSH], Receptors, Estrogen/metabolism [MeSH], Adult [MeSH], Biopsy [MeSH], Receptors, Progesterone/metabolism [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Breast Neoplasms/drug therapy [MeSH], Breast Neoplasms/metabolism [MeSH], Middle Aged [MeSH], Lymphocytes, Tumor-Infiltrating/metabolism [MeSH], Neoplasm, Residual/pathology [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Lymphocytes, Tumor-Infiltrating/immunology [MeSH], Biomarkers, Tumor/metabolism [MeSH], Disease-Free Survival [MeSH], Prognosis [MeSH], Ki-67, Female, Receptors, Progesterone
-
14
Autori: a ďalší
Zdroj: J Cancer Res Clin Oncol
Predmety: Male, Adult, Aged, 80 and over, Skin Neoplasms, Research, Middle Aged, Prognosis, 03 medical and health sciences, 0302 clinical medicine, Chemotherapy, Adjuvant, Body Composition, Humans, Female, Muscle, Skeletal, Tomography, X-Ray Computed, Melanoma, Immune Checkpoint Inhibitors, Melanoma/therapy [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Muscle, Skeletal/diagnostic imaging [MeSH], Skin Neoplasms/drug therapy [MeSH], Low skeletal muscle mass, Tomography, X-Ray Computed [MeSH], Male [MeSH], Muscle, Skeletal/pathology [MeSH], Immune Checkpoint Inhibitors/adverse effects [MeSH], Melanoma/pathology [MeSH], Chemotherapy, Adjuvant/methods [MeSH], Skin Neoplasms/immunology [MeSH], Melanoma/drug therapy [MeSH], Female [MeSH], Adult [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Skin Neoplasms/pathology [MeSH], Melanoma/mortality [MeSH], Body Composition [MeSH], Immune Checkpoint Inhibitors/therapeutic use [MeSH], Adjuvant therapy, Immunotherapy, Prognosis [MeSH], Skin Neoplasms/mortality [MeSH], Body composition, Retrospective Studies, Aged
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38796605
https://repository.publisso.de/resource/frl:6492801 -
15
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: J Cancer Res Clin Oncol
Predmety: Adult, Male, Medicin och hälsovetenskap, Cancer Research, Adolescent, Original Article – Clinical Oncology, Medizin, Adolescent [MeSH], Female [MeSH], Sarcoma, Synovial/therapy [MeSH], Radiotherapy, Adjuvant/methods [MeSH], Combined Modality Therapy/methods [MeSH], Adult [MeSH], Humans [MeSH], Middle Aged [MeSH], Pediatric sarcoma, Infant [MeSH], Male [MeSH], Time [MeSH], Adjuvant therapies, Young Adult [MeSH], Chemotherapy, Chemotherapy, Adjuvant/methods [MeSH], Soft-tissue sarcoma, Child [MeSH], Radiotherapy, Synovial sarcoma, Child, Preschool [MeSH], Medical and Health Sciences, Time, Sarcoma, Synovial, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Humans, Child, ddc:610, Infant, Middle Aged, Combined Modality Therapy, 3. Good health, Chemotherapy, Adjuvant, Child, Preschool, Female, Radiotherapy, Adjuvant, 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
Popis súboru: application/pdf; application/zip
Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00432-021-03614-6.pdf
https://pubmed.ncbi.nlm.nih.gov/34272609
https://link.springer.com/content/pdf/10.1007/s00432-021-03614-6.pdf
https://www.ncbi.nlm.nih.gov/pubmed/34272609
https://link.springer.com/article/10.1007/s00432-021-03614-6
https://paperity.org/p/269661699/the-effect-of-adjuvant -therapies-on-long-term-outcome-for-primary-resected-synovial
https://pubmed.ncbi.nlm.nih.gov/34272609/
https://edoc.mdc-berlin.de/20483/
http://edoc.mdc-berlin.de/20483/1/20483oa.pdf
https://repository.publisso.de/resource/frl:6449888
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-459715 -
16
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Hepatology International. 16:712-727
Predmety: Radiotherapy, Survival, Gallbladder neoplasm, Gallbladder Neoplasms* / radiotherapy, 3. Good health, 03 medical and health sciences, Neoplasm Recurrence, 0302 clinical medicine, Local, Adjuvant / methods, Gallbladder Neoplasms* / pathology, Humans, Gallbladder Neoplasms, Radiotherapy, Adjuvant, Neoplasm Recurrence, Local, Adjuvant
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/35532861
-
17
Autori: a ďalší
Zdroj: Polack, M, Smit, M A, van Pelt, G W, Roodvoets, A G H, Meershoek-Klein Kranenbarg, E, Putter, H, Gelderblom, H, Crobach, A S L P, Terpstra, V, Petrushevska, G, Gašljević, G, Kjær-Frifeldt, S, de Cuba, E M V, Bulkmans, N W J, Vink, G R, Al Dieri, R, Tollenaar, R A E M, van Krieken, J H J M, Mesker, W E & UNITED Collaboration 2024, 'Results from the UNITED study : a multicenter study validating the prognostic effect of the tumor–stroma ratio in colon cancer', ESMO Open, vol. 9, no. 4, 102988. https://doi.org/10.1016/j.esmoop.2024.102988
Predmety: colon cancer, disease-free survival, pathology, tumor microenvironment, tumor–stroma ratio, Prognosis, Prospective Studies, Humans, Middle Aged, Male, Chemotherapy, Adjuvant/methods, Stromal Cells/pathology, Aged, 80 and over, Female, Adult, Colonic Neoplasms/pathology, Neoplasm Staging
Popis súboru: application/pdf
-
18
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Cancer Res Treat
Predmety: Breast Neoplasms / therapy, Androstadienes / pharmacology, Pyridines, Receptor, ErbB-2, Pyridines / therapeutic use, CDK4/6 inhibitor, Piperazines, Estrogen / analysis, Local / therapy, 0302 clinical medicine, Adjuvant / methods, Receptors, Antineoplastic Combined Chemotherapy Protocols, Multicenter Studies as Topic, Piperazines / pharmacology, Piperazines / therapeutic use, Protein Kinase Inhibitors / therapeutic use, Mastectomy, Estrogen / metabolism, Randomized Controlled Trials as Topic, 2. Zero hunger, Breast Neoplasms / mortality, Androstadienes / therapeutic use, Middle Aged, Progression-Free Survival, 3. Good health, Tamoxifen / therapeutic use, Receptors, Estrogen, Chemotherapy, Adjuvant, Pyridines / pharmacology, Breast Neoplasms / pathology, Original Article, Female, Receptor, Endocrine therapy, Adult, Antineoplastic Agents, Hormonal, Antineoplastic Agents, Breast Neoplasms, Progesterone / analysis, 03 medical and health sciences, Clinical Trials, Phase II as Topic, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Chemotherapy, Humans, Clinical Trials, Protein Kinase Inhibitors, Hormonal / therapeutic use, Hormonal / pharmacology, Phase II as Topic, Protein Kinase Inhibitors / pharmacology, Antineoplastic Combined Chemotherapy Protocols / pharmacology, Androstadienes, Neoplasm Recurrence, Local / pathology, Tamoxifen / pharmacology, ErbB-2 / analysis, Progesterone / metabolism, Breast neoplasms, Neoplasm Recurrence, Local, Local / mortality
Prístupová URL adresa: http://www.e-crt.org/upload/pdf/crt-2020-1246.pdf
https://pubmed.ncbi.nlm.nih.gov/33332933
http://www.e-crt.org/upload/pdf/crt-2020-1246.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291192
https://www.e-crt.org/journal/view.php?number=3193
https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/89435
https://snucm.elsevierpure.com/en/publications/implications-of-tamoxifen-resistance-in-palbociclib-efficacy-for-
https://pubmed.ncbi.nlm.nih.gov/33332933/ -
19
Autori: a ďalší
Zdroj: Strahlenther Onkol
Predmety: Female [MeSH], Mastectomy, Segmental [MeSH], Radiotherapy, Adjuvant/methods [MeSH], Adjuvant radiation therapy, Humans [MeSH], Breast Neoplasms/drug therapy [MeSH], Retrospective Studies [MeSH], Breast Neoplasms/radiotherapy [MeSH], Boost, Original Article, Early breast cancer, Breast-conservation therapy, Neoplasm Recurrence, Local [MeSH], Breast Neoplasms/surgery [MeSH], Breast/radiation effects [MeSH], Intraoperative radiotherapy, Breast Neoplasms, Mastectomy, Segmental, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Humans, Female, Radiotherapy, Adjuvant, Breast, Neoplasm Recurrence, Local, Retrospective Studies
Popis súboru: pdf
Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00066-021-01785-2.pdf
https://pubmed.ncbi.nlm.nih.gov/33938966
https://link.springer.com/content/pdf/10.1007/s00066-021-01785-2.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397646
https://europepmc.org/article/MED/33938966
https://link.springer.com/article/10.1007/s00066-021-01785-2
https://repository.publisso.de/resource/frl:6448667 -
20
Autori: a ďalší
Zdroj: Strahlenther Onkol
Predmety: 03 medical and health sciences, Logistic Models, 0302 clinical medicine, Humans, Original Article, Breast Neoplasms, Female, Radiation Dose Hypofractionation, Radiotherapy, Adjuvant, Dose Fractionation, Radiation, Female [MeSH], Radiotherapy, Adjuvant/methods [MeSH], Humans [MeSH], Breast cancer, Logistic Models [MeSH], Breast Neoplasms/radiotherapy [MeSH], Hypofractionation, Radiation Dose Hypofractionation [MeSH], Dose Fractionation, Radiation [MeSH], Radiotherapy, Breast Neoplasms/pathology [MeSH], Guideline implementation, 3. Good health
Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00066-020-01730-9.pdf
https://pubmed.ncbi.nlm.nih.gov/33320286
https://pubmed.ncbi.nlm.nih.gov/33320286/
https://www.ncbi.nlm.nih.gov/pubmed/33320286
https://link.springer.com/article/10.1007/s00066-020-01730-9
https://link.springer.com/content/pdf/10.1007/s00066-020-01730-9.pdf
https://portal.dnb.de/opac.htm?method=simpleSearch&cqlMode=true&query=idn%3D1225605598
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397631
https://repository.publisso.de/resource/frl:6443186
Full Text Finder 
Nájsť tento článok vo Web of Science 
Full Text